[Evaluation of the therapeutic effectiveness and tolerance of flunisolide (VAL 679) and of flunisolide plus salbutamol (VAL 679/A) in chronic obstructive bronchopneumopathies].
D000287:Administration, Topical; D000328:Adult; D000368:Aged; D000420:Albuterol / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D005260:Female; D005446:Fluocinolone Acetonide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011656:Pulmonary Emphysema / Q000188:drug therapy
D000893:Anti-Inflammatory Agents; D005446:Fluocinolone Acetonide; C007734:flunisolide; D000420:Albuterol
Valutazione dell'efficacia terapeutica e della tollerabilità del flunisolide (VAL 679) e del flunisolide + salbutamolo (VAL 679/A) nelle broncopneumopatie croniche ostruttive.